In early April, biotechnology company Can-Fite BioPharma Ltd announced the completion of pre-clinical studies into the potential of using a specific cannabis compound to inhibit liver cancer cell growth. The compound highlighted in the company’s study on cannabis for liver cancer is a CBD potent T3/C15 cannabis fraction.  “These findings present a novel therapeutic opportunity…

The post Preclinical studies show that cannabis compound hinders the growth of liver cancer cells appeared first on Cannabis News Box.

Continue reading…

Trending stories from over 100 sources, YouTube and Twitter
Our archive contains 59,796 news items. 137 articles added this week.